TII will also seek approval of its shareholders for incremental increase in investment in Cellestial up to Rs 139 cr, based on its business requirements so that the total investment in the start-up will not exceed Rs 300 cr. The acquisition will be completed before March 15, 2022, subject to shareholders approval and satisfactory completion of the conditions of the agreements executed between the parties, the filing said. TII said this new subsidiary will consolidate the electric 3W venture and other EV-related ventures. “The company will be infusing initial capital to the extent of Rs 350 crore into the new subsidiary for clean mobility.”